CLU and Alzheimer disease: In AD, the degree of region-specific synapse loss better correlates with cognitive decline than amyloid plaques, NFTs and neuron loss (173, 174) and genetic variants of complement receptor 1 (CR1) and clusterin (CLU, apolipoprotein J), which are parts of the complement system, are identified as AD risk factors by genome wide association studies (175).